In the news release, Matrix Medical Network Announces Strategic Partnership with Molecular Testing Labs to Enhance In-Home Diagnostic Offerings, issued 23-Jul-2025 by Matrix Medical Network over PR Newswire, we are advised by the company that the first paragraph, first sentence, should read “CareNexa, LLC dba Molecular Testing Labs” rather than “Molecular Testing Labs” as originally issued inadvertently. The “About Molecular Testing Labs” paragraph has also been updated. The complete, corrected release follows:
Leader In Delivering Home-Based Health and Care Services Partners with Laboratory Known for Quality, Reliability and Innovation
NASHVILLE, Tenn., July 23, 2025 /PRNewswire/ — Matrix Medical Network (Matrix), a leader in delivering high quality, home-based health and care services, announced a new strategic partnership with CareNexa, LLC dba Molecular Testing Labs (MTL), a CLIA- and New York state-certified, CAP-accredited laboratory renowned for its innovation and quality in molecular diagnostics. The collaboration represents an additional step in Matrix’s mission to improve health outcomes for patients and deliver greater value to clients.
Matrix selected MTL after a thorough evaluation of their advanced capabilities, high-quality standards and shared vision for delivering accessible care. This strategic decision brings several key enhancements that will improve the quality, flexibility and reliability of Matrix’s in-home screening services:
-
Improved Diagnostic Accuracy: MTL’s use of advanced molecular techniques and validated high-sensitivity analysis ensures reliable and precise test results.
-
Expanded Access to Care: Novel sample collection kits designed by MTL will allow safe and convenient testing from virtually any location, including underserved and remote areas.
-
Enhanced Patient Experience: Patients will benefit from more flexible testing options, including in-home specimen collection and leave behind and shipped kits, supported by educational outreach and patient-centric engagement.
-
Driving Better Outcomes: By integrating actionable insights from AI-driven analytics and streamlining the diagnostic process, Matrix and MTL aim to close care gaps and improve chronic illness detection and follow-up care opportunities.
“At Matrix, we’re committed to improving lives and delivering high-quality patient-centered care, wherever people call home,” said Catherine J. Tabaka, President & CEO of Matrix. “This partnership further demonstrates our commitment to safe and accurate testing and screening as an important element of whole-person care.”
link